AMIDE-BASED MUTUAL PRODRUG: SYNTHESIS AND EVALUATION STUDIES
DOI:
https://doi.org/10.37547/ajbspi/Volume03Issue08-03Keywords:
Amide-based mutual prodrug, synthesis, drug deliveryAbstract
Amide-based mutual prodrugs have gained significant attention in recent years as promising pharmaceutical candidates due to their potential to enhance drug solubility, stability, and bioavailability. This study focuses on the synthesis and evaluation of a novel amide-based mutual prodrug designed to improve the delivery and therapeutic efficacy of a parent drug. The synthesis involves the chemical conjugation of two active moieties through an amide bond to form a single prodrug entity. The evaluation encompasses a comprehensive assessment of physicochemical properties, in vitro release kinetics, enzymatic hydrolysis, and pharmacological activity of the prodrug compared to the parent drug. The results obtained shed light on the prodrug's potential advantages and challenges, providing valuable insights for further optimization and development. The findings of this study contribute to the growing body of knowledge on amide-based mutual prodrugs and their application in pharmaceutical research.
References
Kristiina M. Huttunen, Hannu Raunio and Jarkko Rautio, Prodrugs—from Serendipity to Rational Design, Pharmacological Reviews, 2011, 63(3), 750-71.
Jarkko Rautio, Hanna Kumpulainen, Tycho Heimbach, Reza Oliyai, Dooman Oh, Tomi Järvinen & Jouko Savolainen Prodrugs: design and clinical applications. Nature Reviews Drug Discovery 2008, 7, 255-70.
Jana S, Mandlekar S, Marathe P. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.Curr Med Chem. 2010;17(32):3874-908.
Bhosle, D.; Bharambe, S.; Gairola, Neha; Dhaneshwar, Suneela S. Mutual Prodrug concept: fundamentals and applications, Ind. J. Pharm. Sci., 2006, 68(3), 286.
Asif Husain, Priyanka Ahuja, M. Shaharyar, Aftab Ahmad, Ibraheem Ahmed I. Mkhalid, M.M. Alam, M. Akhter, and M.S. Zaman (2014), Synthesis, biological activities and pharmacokinetics studies of a mutual prodrug of aceclofenac and paracetamol. Med. Chem. Res., 23(3) 1077-1083.
Halen PK, Murumkar PR, Yadav MR, Giridhar R., Prodrug designing of NSAIDs. Mini Rev. Med. Chem, 2009; 9(1): 124-39.
Davies J. Nature, 1996; 383: 219-20.
Zaman K., Tuberculosis: A global Health Problem, J Health Popul Nutr., 2010, 28(2), 111-13.
Janin YL. Antituberculosis drugs: Ten years of research. Bioorg Med Chem. 2007; 15(7): 2479-513.
Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martin-Casabona N, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis.2007;13:380–7
